Envoy Medical, Inc. (NASDAQ:COCH) Sees Large Growth in Short Interest

Envoy Medical, Inc. (NASDAQ:COCH) was the target of a large growth in short interest in October. As of October 31st, there was short interest totalling 46,900 shares, a growth of 6.3% from the October 15th total of 44,100 shares. Currently, 0.7% of the company’s stock are sold short. Based on an average daily trading volume, of 227,800 shares, the short-interest ratio is presently 0.2 days.

Analyst Upgrades and Downgrades

A number of analysts recently commented on COCH shares. Ascendiant Capital Markets boosted their target price on Envoy Medical from $8.50 to $8.75 and gave the company a “buy” rating in a research report on Tuesday, September 3rd. Brookline Capital Management began coverage on Envoy Medical in a research note on Monday, October 14th. They set a “buy” rating and a $9.00 price target for the company.

Hedge Funds Weigh In On Envoy Medical

An institutional investor recently bought a new position in Envoy Medical stock. Virtu Financial LLC bought a new position in Envoy Medical, Inc. (NASDAQ:COCH) during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 14,045 shares of the company’s stock, valued at approximately $55,000. Virtu Financial LLC owned about 0.07% of Envoy Medical as of its most recent SEC filing. 8.59% of the stock is currently owned by institutional investors.

Envoy Medical Price Performance

Shares of NASDAQ COCH traded up $0.08 during midday trading on Tuesday, reaching $2.06. The company’s stock had a trading volume of 31,081 shares, compared to its average volume of 204,492. Envoy Medical has a 12-month low of $0.78 and a 12-month high of $11.46. The firm has a 50 day moving average price of $2.76 and a 200-day moving average price of $2.67.

Envoy Medical Company Profile

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.